We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+18.99%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13.3B
AUM Growth
+$2.87B
Cap. Flow
+$1.1B
Cap. Flow %
8.24%
Top 10 Hldgs %
20.04%
Holding
2,557
New
285
Increased
1,225
Reduced
862
Closed
103

Sector Composition

Rank Sector Weight
1 Technology 8.95%
2 Consumer Discretionary 4.49%
3 Healthcare 4.46%
4 Financials 4.28%
5 Communication Services 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PULM icon
2426
Pulmatrix
PULM
$5.84M
$18K ﹤0.01%
+510
New +$16.2K
TLPH icon
2427
Talphera
TLPH
$72.7M
$18K ﹤0.01%
+764
New +$21.3K
AUD
2428
DELISTED
Audacy, Inc.
AUD
$18K ﹤0.01%
+13,055
New +$18.5K
PVL
2429
Permianville Royalty Trust
PVL
$57.8M
$17K ﹤0.01%
+13,785
New +$18.2K
TNXP icon
2430
Tonix Pharmaceuticals
TNXP
$205M
0
TYME
2431
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$17K ﹤0.01%
13,000
TTOO
2432
DELISTED
T2 Biosystems, Inc
TTOO
$16K ﹤0.01%
3
+1
+50% +$4.25K
BGG
2433
DELISTED
Briggs & Stratton Corp.
BGG
$16K ﹤0.01%
12,550
+1,530
+14% +$2.81K
CRVO icon
2434
CervoMed
CRVO
$41.5M
$14K ﹤0.01%
+187
New +$11.4K
TEUM
2435
DELISTED
Pareteum Corporation
TEUM
$14K ﹤0.01%
22,035
-3,264
-13% -$1.8K
OTLK icon
2436
Outlook Therapeutics
OTLK
$206M
$13K ﹤0.01%
+500
New +$8.92K
PLM
2437
DELISTED
PolyMet Mining Corp.
PLM
$11K ﹤0.01%
2,609
-800
-23% -$2.32K
CHRD icon
2438
Chord Energy
CHRD
$7.53B
$9K ﹤0.01%
12,322
-9,418
-43% -$6.09K
AMTX icon
2439
Aemetis
AMTX
$126M
$8K ﹤0.01%
+10,000
New +$7.27K
VAL
2440
DELISTED
Valaris plc Class A Ordinary Share
VAL
$8K ﹤0.01%
+11,775
New +$6.66K
GPL
2441
DELISTED
Great Panther Mining Limited
GPL
$7K ﹤0.01%
1,470
VIVS
2442
VivoSim Labs
VIVS
$1.16M
$6K ﹤0.01%
42
ZN
2443
DELISTED
Zion Oil & Gas, Inc.
ZN
$6K ﹤0.01%
21,104
+4,241
+25% +$1.15K
HCR
2444
DELISTED
Hi-Crush Inc. Common Stock
HCR
$5K ﹤0.01%
34,829
+5,660
+19% +$1.65K
AXAS
2445
DELISTED
Abraxas Petroleum Corp
AXAS
$4K ﹤0.01%
810
+55
+7% +$249
TMUSR
2446
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$2K ﹤0.01%
+10,728
New +$3.01K
AHRT
2447
AH Realty Trust
AHRT
$501M
-11,632
Closed -$124K
AMZA icon
2448
InfraCap MLP ETF
AMZA
$478M
-10,656
Closed -$115K
AVTX icon
2449
Avalo Therapeutics
AVTX
$1.05B
-7
Closed -$48K
BGC icon
2450
BGC Group
BGC
$5.12B
-15,862
Closed -$40K

Similar funds

Cambridge Investment Research Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Cambridge Investment Research Advisors held 2,557 positions worth $13.3B, up 28% from $10.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $1.1B of net new capital in Q2 2020, opening 285 new positions and adding to 1,225 existing holdings. Its largest new stake was FS KKR Capital Corp. II: 1,991,449 shares worth $25.7M.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $50.5M trimmed.

  • Cambridge Investment Research Advisors's largest Q2 2020 buy was FS KKR Capital Corp. II: 1,991,449 shares worth $25.7M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q2 2020, an estimated $87.9M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2020 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $50.5M.
  • Cambridge Investment Research Advisors fully exited Raytheon Company in Q2 2020, selling an estimated $7.24M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $13.3B portfolio in Q2 2020.
  • Cambridge Investment Research Advisors opened 285 new positions and closed 103 in Q2 2020.
  • Cambridge Investment Research Advisors's portfolio value rose 28% quarter-over-quarter to $13.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.